Welcome to LookChem.com Sign In|Join Free

CAS

  • or

28315-93-7

Post Buying Request

28315-93-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28315-93-7 Usage

Chemical Properties

light yellow to beige or pinkish crystalline

Uses

Different sources of media describe the Uses of 28315-93-7 differently. You can refer to the following data:
1. A metabolite of Levobunolol (L335000) and d-Bunolol (L335010).
2. 5-Hydroxy-1-tetralone, is used as a metabolite of Levobunolol (L335000) and d-Bunolol (L335010). It is also used as a reagent for the determination of hexoses and oligosaccharides by a fluorescence technique. A reagent that is used for fluorescence determination of enzyme activity. Some of the other applications include as internal standard during HPLC determination of 4-hydroxymephenytoin (4-OH-M) in human urine, as fluorescent labeling reagent during micro detection of glycosphingolipid on TLC plates, in synthesis of 1,2,3,4-tetrahydro-5H-1-benzazepine-quinone derivatives, in synthesis of new chiral oxathiane.

Check Digit Verification of cas no

The CAS Registry Mumber 28315-93-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,3,1 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28315-93:
(7*2)+(6*8)+(5*3)+(4*1)+(3*5)+(2*9)+(1*3)=117
117 % 10 = 7
So 28315-93-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H10O2/c11-9-5-1-3-7-8(9)4-2-6-10(7)12/h1,3,5,11H,2,4,6H2

28315-93-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17034)  5-Hydroxy-1-tetralone, 99%   

  • 28315-93-7

  • 1g

  • 502.0CNY

  • Detail
  • Alfa Aesar

  • (A17034)  5-Hydroxy-1-tetralone, 99%   

  • 28315-93-7

  • 5g

  • 1914.0CNY

  • Detail
  • Alfa Aesar

  • (A17034)  5-Hydroxy-1-tetralone, 99%   

  • 28315-93-7

  • 25g

  • 7718.0CNY

  • Detail

28315-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-hydroxy-3,4-dihydro-2H-naphthalen-1-one

1.2 Other means of identification

Product number -
Other names 5-hydroxy-1-oxotetraline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28315-93-7 SDS

28315-93-7Synthetic route

1,2,3,4-tetrahydro-1,5-dihydroxy-naphthalene
40771-26-4

1,2,3,4-tetrahydro-1,5-dihydroxy-naphthalene

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With tert.-butylhydroperoxide; zircornium(IV) n-propoxide In dichloromethane at 20℃; for 18h;96%
1,5-dihydroxynaphthalene
83-56-7

1,5-dihydroxynaphthalene

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With aluminum tri-bromide; cyclohexane In various solvent(s) at 25℃; for 48h;88%
With palladium on activated charcoal; ammonium formate In water; butan-1-ol at 120℃; for 3h; Temperature; Solvent; Reagent/catalyst; Further stages;83.3%
Stage #1: 1,5-dihydroxynaphthalene With hydrogen; sodium hydroxide; palladium 10% on activated carbon In water; isopropyl alcohol at 20 - 80℃; under 5171.62 Torr; Autoclave;
Stage #2: With hydrogenchloride In water pH=~ 2;
60%
Stage #1: 1,5-dihydroxynaphthalene With hydrogen; sodium hydroxide; palladium 10% on activated carbon In water; isopropyl alcohol at 80℃; under 5171.62 Torr; for 20h; Autoclave;
Stage #2: With hydrogenchloride In water pH=~ 2;
60%
With palladium 10% on activated carbon; hydrogen; sodium hydroxide In water; isopropyl alcohol at 80℃; under 8250.83 Torr; for 24h; Autoclave;53%
5-Methoxy-1-tetralone
33892-75-0

5-Methoxy-1-tetralone

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With hydrogen bromide; acetic acid for 0.75h; Heating;85%
With 1-N-ferrocenylmethyl benzimidazole tagged polymer In N,N-dimethyl-formamide Reflux;82%
With hydrogen bromide In acetic acid for 24h; Heating;
4,5-dihydro-3H-benzo[b]oxepin-2-one
3041-17-6

4,5-dihydro-3H-benzo[b]oxepin-2-one

A

2-hydroxybenzenebutanoic acid
35387-19-0

2-hydroxybenzenebutanoic acid

B

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With PPA at 80℃; for 3h;A 55%
B 7%
2-allyl-3-hydroxy-benzaldehyde
79950-42-8

2-allyl-3-hydroxy-benzaldehyde

A

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

B

4-hydroxy-2-methyl-2,3-dihydro-1H-inden-1-one
99678-01-0

4-hydroxy-2-methyl-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With acetic acid; L-proline at 120℃; for 24h; Green chemistry;A 40%
B 42%
3,4-dihydronaphthalene-1(2H)-one
529-34-0

3,4-dihydronaphthalene-1(2H)-one

A

7-hydroxy-1-tetralone
22009-38-7

7-hydroxy-1-tetralone

B

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

C

5,8-dihydroxy-1-tetralone
1077-69-6

5,8-dihydroxy-1-tetralone

Conditions
ConditionsYield
With dihydrogen peroxide; hydrogen fluoride; antimony pentafluoride at -40℃; for 0.5h; Mechanism; Product distribution;A 30%
B 34%
C 5%
With dihydrogen peroxide; hydrogen fluoride; antimony pentafluoride at -40℃; for 0.5h;A 30%
B 34%
C 5%
5,6,7,8-tetrahydronaphthalen-1-yl acetate
91028-13-6

5,6,7,8-tetrahydronaphthalen-1-yl acetate

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With chromium(VI) oxide; acetic anhydride; acetic acid at 40℃; und Erhitzen des erhaltenen 5-Acetoxy-1-oxo-tetralins C12H12O3 mit wss.-aethanol.NaOH unter Wasserstoff; substances of mp: about 210 degree;
(4aSR,8aSR)-octahydronaphthalene-1,5-dione
13913-82-1, 42245-84-1, 42245-85-2, 89448-15-7, 89448-20-4

(4aSR,8aSR)-octahydronaphthalene-1,5-dione

(+-)-1.5-dioxo-trans-decalin

(+-)-1.5-dioxo-trans-decalin

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With potassium hydroxide substances of mp: 157 degree;
5-amino-1-oxo-tetralin

5-amino-1-oxo-tetralin

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With sulfuric acid Diazotization; substances of mp: about 210 degree;
naphthlindiol-(1.5)

naphthlindiol-(1.5)

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

Conditions
ConditionsYield
With kieselguhr; tetralin; nickel at 120 - 180℃; under 7355.08 - 14710.2 Torr; Hydrogenation; substances of mp: 157 degree;
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2SO4 / 20 °C
2: acetic acid; acetic acid anhydride; CrO3 / 40 °C / und Erhitzen des erhaltenen 5-Acetoxy-1-oxo-tetralins C12H12O3 mit wss.-aethanol.NaOH unter Wasserstoff
View Scheme
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

6-bromo-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one

6-bromo-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one

Conditions
ConditionsYield
With N-Bromosuccinimide; diisopropylamine In dichloromethane at 25℃; for 4h; Inert atmosphere;89%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

benzaldehyde
100-52-7

benzaldehyde

(2E)-2-benzylidene-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one
42022-29-7

(2E)-2-benzylidene-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one

Conditions
ConditionsYield
With hydrogenchloride In methanol; water Claisen-Schmidt Condensation; Reflux;88%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

tert-butyl({[(2S)-oxiran-2-yl]methyl})amine
45720-12-5

tert-butyl({[(2S)-oxiran-2-yl]methyl})amine

levobutanolol; (S)-(-)-5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3.4-dihydro-1(2H)-naphtalenone monohydrochloride

levobutanolol; (S)-(-)-5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3.4-dihydro-1(2H)-naphtalenone monohydrochloride

Conditions
ConditionsYield
With sodium ethanolate In methanol; water at 50℃; for 5h; Solvent; Reagent/catalyst; Temperature;87.3%
1-(3-chloropropyl)-4-(2-ethoxyphenyl)-piperazine
103997-60-0

1-(3-chloropropyl)-4-(2-ethoxyphenyl)-piperazine

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

5-{3-[4-(2-ethoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

5-{3-[4-(2-ethoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

Conditions
ConditionsYield
86%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

5-(methoxymethoxy)tetralin-1-one

5-(methoxymethoxy)tetralin-1-one

Conditions
ConditionsYield
Stage #1: 5-Hydroxy-1-tetralone With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: chloromethyl methyl ether In tetrahydrofuran at 20℃; for 2h;
85%
1-(3-Chloropropyl)-4-(p-methoxyphenyl)piperazine
21279-79-8

1-(3-Chloropropyl)-4-(p-methoxyphenyl)piperazine

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

5-{3-[4-(4-methoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

5-{3-[4-(4-methoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

Conditions
ConditionsYield
84.5%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

methanesulfonic acid 5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl ester

methanesulfonic acid 5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at -10 - 20℃; for 18h;80%
With triethylamine In dichloromethane at 10℃;
With triethylamine In dichloromethane at -10℃;
With triethylamine at -10℃;
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

1-(2-methoxyphenyl)-4-(3-chloropropyl)piperazine
21279-77-6

1-(2-methoxyphenyl)-4-(3-chloropropyl)piperazine

5-{3-[4-(2-methoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

5-{3-[4-(2-methoxy-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

Conditions
ConditionsYield
78.8%
1-(2-chlorophenyl)-4-(3-chloropropyl)-piperazine
52536-36-4

1-(2-chlorophenyl)-4-(3-chloropropyl)-piperazine

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

5-{3-[4-(2-chloro-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

5-{3-[4-(2-chloro-phenyl)-piperazin-1-yl]-propoxy}-3,4-dihydro-2H-naphthalen-1-one

Conditions
ConditionsYield
78%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

cyclopropylcarbinyl bromide
7051-34-5

cyclopropylcarbinyl bromide

5-(cyclopropylmethoxy)-3,4-dihydronaphthalen-1(2H)-one
1480018-37-8

5-(cyclopropylmethoxy)-3,4-dihydronaphthalen-1(2H)-one

Conditions
ConditionsYield
With potassium carbonate In butanone at 80℃;78%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

3,4-dichlorobenzaldehyde
6287-38-3

3,4-dichlorobenzaldehyde

(2E)-2-(3',4'-dichlorobenzylidene)-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one

(2E)-2-(3',4'-dichlorobenzylidene)-5-hydroxy-3,4-dihydronaphthalen-1(2H)-one

Conditions
ConditionsYield
With hydrogenchloride In methanol; water Claisen-Schmidt Condensation; Reflux;78%
5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

(+/-)-2-fluoro-5-hydroxy-3,4-dihydro-1(2H)-naphthalenone

(+/-)-2-fluoro-5-hydroxy-3,4-dihydro-1(2H)-naphthalenone

Conditions
ConditionsYield
With 1-fluoro-4-hydroxy-1,4-diazoniabicyclo[2,2,2]octane-1,4-bis(tetrafluoroborate) In methanol for 0.5h; Heating;77%
3-[4-(2-methylphenyl)-piperazino]-propyl chloride
6323-15-5

3-[4-(2-methylphenyl)-piperazino]-propyl chloride

5-Hydroxy-1-tetralone
28315-93-7

5-Hydroxy-1-tetralone

5-[3-(4-o-tolyl-piperazin-1-yl)-propoxy]-3,4-dihydro-2H-naphthalen-1-one

5-[3-(4-o-tolyl-piperazin-1-yl)-propoxy]-3,4-dihydro-2H-naphthalen-1-one

Conditions
ConditionsYield
73.4%

28315-93-7Relevant articles and documents

The evaluation of 1-tetralone and 4-chromanone derivatives as inhibitors of monoamine oxidase

Cloete, Stephanus J.,N’Da, Clarina I.,Legoabe, Lesetja J.,Petzer, Anél,Petzer, Jacobus P.

, p. 491 - 507 (2020/10/02)

Abstract: Monoamine oxidase (MAO) is of much clinical relevance, and inhibitors of this enzyme are used in the treatment for neuropsychiatric and neurodegenerative disorders such as depression and Parkinson’s disease. The present study synthesises and evaluates the MAO inhibition properties of a series of 33 1-tetralone and 4-chromanone derivatives in an attempt to discover high-potency compounds and to expand on the structure–activity relationships of MAO inhibition by these classes. Among these series, eight submicromolar MAO-A inhibitors and 28 submicromolar MAO-B inhibitors are reported, with all compounds acting as specific inhibitors of the MAO-B isoform. The most potent inhibitor was a 1-tetralone derivative (1h) with IC50 values of 0.036 and 0.0011?μM for MAO-A and MAO-B, respectively. Interestingly, with the reduction of 1-tetralones to the corresponding alcohols, a decrease in MAO inhibition potency is observed. Among these 1-tetralol derivatives, 1p (IC50 = 0.785?μM) and 1o (IC50 = 0.0075?μM) were identified as particularly potent inhibitors of MAO-A and MAO-B, respectively. Potent compounds such as those reported here may act as leads for the future development of MAO-B specific inhibitors. Graphic abstract: The present study describes the MAO inhibitory activities of a series of 1-tetralone and 4-chromanone derivatives. Numerous high-potency MAO-B specific inhibitors were identified.[Figure not available: see fulltext.].

Preparation method of levobunolol hydrochloride

-

Paragraph 0041-0043-0044; 0048-0049; 0051-0052; 0054-0055, (2019/01/17)

The invention provides a preparation method of levobunolol hydrochloride. The preparation method comprises steps as follows: S-1-tert-butyl-epoxy methylamine and 1,2,3,4-tetrahydro-5-hydroxynaphthalen-1-one are subjected to a substitution reaction, and after acidizing treatment is performed, a target product, namely levobunolol hydrochloride, is prepared. With the adoption of the method, regioselectivity of the reaction is greatly improved, side reactions are avoided, yield of levobunolol hydrochloride is effectively increased, optical purity of levobunolol hydrochloride is effectively improved, yield reaches 87.3%, and ee value exceeds 99%.

Enantioselective halogenative semi-pinacol rearrangement: Extension of substrate scope and mechanistic investigations

Romanov-Michailidis, Fedor,Romanova-Michaelides, Maria,Pupier, Marion,Alexakis, Alexandre

supporting information, p. 5561 - 5583 (2015/03/30)

The present Full Paper article discloses a survey of our recent results obtained in the context of the enantioselective halogenation-initiated semi-pinacol rearrangement. Commencing with the fluorination/semi-pinacol reaction first and moving to the heavier halogens (bromine and iodine) second, the scope and limitations of the halogenative phase-transfer methodology will be discussed and compared. An extension of the fluorination/semi-pinacol reaction to the ring-expansion of five-membered allylic cyclopentanols will be also described, as well as some preliminary results on substrates prone to desymmetrization will be given. Finally, the present manuscript will culminate with a detailed mechanistic investigation of the canonical fluorination/semi-pinacol reaction. Our mechanistic discussion will be based on in situ reaction progress monitoring, complemented with substituent effect, kinetic isotopic effect and non-linear behaviour studies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28315-93-7